100
Participants
Start Date
October 23, 2024
Primary Completion Date
May 13, 2025
Study Completion Date
June 30, 2025
Immunohistochemistry and in situ hybridisation analysis
immunohistochemistry and in situ hybridisation analysis for several markers, including p53, beta-Catenin and albumin, but also markers considered diagnostic for HCC such as Glutamin Synthetase, Glypican-3 and HSP70, to identify a more rational diagnostic-prognostic algorithm for primary liver lesions.
RECRUITING
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER